Navigation Links
Is clinicians' decision making affected by 'precious baby' phenomenon?
Date:11/4/2013

Parents who conceive through assisted reproductive technologies (ART) are likely to receive different medical advice in relation to prenatal testing than those who conceive naturally, academics have suggested.

An international study has revealed that almost 45% of clinicians would immediately recommend a 37-year-old mother undergo amniocentesis an invasive prenatal test which screens for Down's syndrome if she had conceived naturally. However, just 19% of doctors would recommend the procedure for a mother whose baby had been conceived through assisted technologies.

Previous research papers have suggested parents who conceive through ART may be more likely to opt for birth by Caesarean section, rather than a natural birth, in an attempt to minimise any perceived risk to their baby. But the academics, in a paper published in the Human Reproduction scientific journal, suggest there may now be evidence that doctors are also affected by the so-called 'precious baby' phenomenon.

Dr Yaniv Hanoch, Associate Professor in Psychology at Plymouth University, co-wrote the study. He said: "Some pregnancies are deemed by parents to be more valuable than others, particularly if conception has taken several courses of assisted reproductive treatment to achieve. But you might expect clinical recommendations regarding pregnancies to remain consistent, particularly when it comes to tests for serious medical conditions. However, this study demonstrates there may be a tendency for clinicians to be affected by the nature of the pregnancy before determining the parents' wishes."

The study was undertaken by Dr Hanoch alongside Dr Naama Srebnik and Dr Avi Tsafrir, from the Department of Obstetrics and Gynecology at Hebrew University, Jerusalem; Dr Talya Miron-Shatz from the Center for Medical Decision Making, Ono Academic College, and Dr Jonathan J Rolison, from the School of Psychology at Queen's University, Belfast.

It used answers from around 160 obstetricians and gynaecologists, who completed an anonymous questionnaire based around a hypothetical scenario, with around half told the expectant mother had conceived naturally and the other half told ART had been employed.

In total, almost a third (31.9%) immediately recommended amniocentesis, while a further 31.3% recommended the procedure having sought further clarification about the apparent high risk to mother and baby. However, this figure differed when the nature of the pregnancy was taken into account.

The clinicians' breadth of experience and use of the procedure were also taken into account, with results showing longer service in the medical profession to have some correlation with their willingness to offer amniocentesis.

The researchers added: "Even without a medical indication, more clinicians would recommend amniocentesis to a woman with normal screening test results in a spontaneous pregnancy than to one who had undergone ART. Thus far, researchers have provided only indirect evidence to support the claim of differential management of ART pregnancies, but our findings show they do not appear to be immune to the 'precious baby' phenomenon."


'/>"/>

Contact: Alan Williams
alan.williams@plymouth.ac.uk
01-752-588-004
University of Plymouth
Source:Eurekalert

Related medicine news :

1. Astronaut Story Musgrave, MD, to Deliver a Keynote Address at Pri-Med East Conference & Exhibition for Primary Care Clinicians
2. Nineteen Clinicians Receive Advanced Certifications at BenchMark Physical Therapy
3. Clinicians often wait for red flags before discussing elderly driving
4. AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards
5. AMD Global Telemedicine Increases Data Sharing Capabilities for Clinicians and Physicians with AGNES 3.1.0
6. Survey of clinicians: User satisfaction with electronic health records has decreased since 2010
7. When clinicians and researchers look outside the box
8. New tool for clinicians proves effective predictor of lung cancer risk
9. Disorders of consciousness: How should clinicians respond to new therapeutic interventions?
10. New study suggests clinicians overlook alcohol problems if patients are not intoxicated
11. Zane Benefits Publishes New Information on the ACA Penalty vs. Premium Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their ... The patient is doing more than filling out a survey; in many cases health ... increasing emphasis in health care and research on the importance of active engagement with ...
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
Breaking Medicine Technology: